Tag: cancer

Sydney, 20 July 2022 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is lending its support to Glioblastoma (GBM) Awareness Day 2022 and remains firmly focused on developing a treatment that may help improve the […]

Market Overview “The Global Cancer Molecular Diagnostics Market is expected to grow at a high CAGR during the forecasting period (2021-2028)”. Cancer molecular diagnostics include the detection, diagnosis, sub-classification, prognosis, and monitoring response to therapy. These techniques identify the alterations in DNA […]

License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies Boca Raton, FL, October 7, 2021 – Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”) announced today that the Company has reached […]

DelveInsight’s ‘Neoantigen based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast by 2035‘ report provides an in-depth understanding of Neoantigen based Personalized Cancer therapeutic Vaccines & the Neoantigen-based personalized cancer therapeutic vaccines emerging market trends in the US, EU5 […]

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access Roots Analysis is pleased […]

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication […]

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication […]

The Fireside Chat will take place on Wednesday, February 10th at 2:00 pm Eastern Time. The live event will also be archived and available for replay. The Fireside Chat is open for all investors to access. “We are excited to […]

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions   Roots Analysis is pleased to announce the […]

 Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication […]

Boca Raton, FL (October 16, 2020) – Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it has entered into an Exclusive Evaluation and Commercialization […]

Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights […]

Sydney, Australia and Los Angeles, California 21 July 2020 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement […]

The Brave & Beautiful Blood Cancer Foundation announces its 1st annual Healthy Families Festival featuring a 1 Mile Warrior Walk in a Fight to End Blood Cancer The Brave & Beautiful Blood Cancer Foundation partners with The City of Las […]

Lloyd Bell Settles Medical Malpractice Case Against Kaiser Permanente 24-Year-Old Male Dies After Kaiser Doctors Fail to Diagnose Testicular Cancer for 6 Months ATLANTA, Ga. – October 25, 2019 – Lloyd Bell of Bell Law Firm, Georgia’s preeminent law firm […]

Cancer Drugs and Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy Biologic Therapy, […]